ABVC stock

ABVC Biopharma Inc (ABVC) financials · $35.9M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

ABVC Biopharma Inc (ABVC) $35.9M cap.

Cached income statement (latest stored periods)
LineQ2 2026Q1 2026
Operating Income-$779.5K-$1.57M
Net Income-$736.9K-$1.56M
EPS (Diluted)-$0.03-$0.06
Cached balance sheet (latest stored periods)
LineQ2 2026Q1 2026
Total Assets$19.4M$19.7M
Current Assets$411.7K$648.8K
Cash & Equivalents$31.9K$140.3K
PP&E$12.8M$12.8M
Total Liabilities$7.13M$6.90M
Current Liabilities$5.69M$5.39M
Short-term Debt$59.5K$88.7K
Total Debt$59.5K$88.7K
Shareholders' Equity$10.3M$10.8M
Retained Earnings-$79.2M-$78.4M

† Total Debt: Derived from short-term debt only (no total or long-term debt stored).

Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$2.99M-$1.81M
Investing Cash Flow-$1.21MN/A
Financing Cash Flow$4.64M$1.98M
Net Change in Cash$463.2K$147.0K
These statements as JSON? API free 100/day

FAQ

What is ABVC P/E and revenue?

ABVC Biopharma Inc (ABVC) $35.9M cap.

What is ABVC revenue?

ABVC income-statement cache has no revenue figure yet.

Is ABVC profitable?

ABVC Biopharma Inc last cached net income is -$736.9K (Q2 2026).

What are ABVC total assets?

ABVC Biopharma Inc last cached total assets are $19.4M (Q2 2026).

What is ABVC free cash flow?

No cached cash-flow row for ABVC yet.

Not investment advice. Cached statements, not a live tape.